Dissertation > Excellent graduate degree dissertation topics show

The Expression Study of BRDT-NY Protein

Author: YangLi
Tutor: WangJianJun；ZhengYing
School: Yangzhou University
Course: Pathology and Pathophysiology
Keywords: BRDT-NY protein expression study cancer CT gene
CLC: R73-3
Type: Master's thesis
Year: 2008
Downloads: 28
Quote: 0
Read: Download Dissertation

Abstract


In the past many years, there has been a continuing search for cancer vaccine targets. Owing to their highly tissue-restricted expression in the testis and the various malignancies, CT antigens are being vigorously pursued as targets for therapeutic cancer vaccines.BRDT-NY gene is a novel alternative splice variant of CT9 （also named BRDT gene）. It is also a kind of Bromodomain gene. Multiple tissue RT-PCR results showed that BRDT-NY gene only expressed in testis, with no expression in other normal human tissues. Till now, the protein expression of BRDT-NY has not been reported.The aims of this study are: First to express and purify recombinant BRDT-NY proteins, then these proteins were used as immunogens, with which a high-titer anti-BRDT-NY polyclonal antibody was successfully obtained by immunization of BalB/c mice; Second to detect the expression of BRDT-NY protein in human normal testis; Third to study the expression of BRDT-NY protein in different malignant tumors. The research divides into following three parts:Part 1. Cloning and expressing the fragments of BRDT-NY gene, and purifying the BRDT-NY recombinant proteinAccording to BRDT-NY nuclear acid sequences,three primer pairs were designed. Three fragments of BRDT-NY gene, named BRDT-NY1, BRDT-NY2, BRDT-NY3. BRDT-NY1, BRDT-NY2, BRDT-NY3, were amplified from pTriplEx2-BRDT-NY by PCR respectively. Then the three fragments were inserted into pET28a+ vector. These recombinant vectors were transformed into E.coli BL21 and induced by IPTG for expressing 6×His-tag fusion protein BRDT-NY1, BRDT-NY2, BRDT-NY3. The proteins were purified and annealed.Part 2. Preparing anti-BRDT-NY polyclonal antibodyThe protein purfied with Ni-NTA were used as antigens to immunize eight months old BALB/c mice for four times. ELISA analysis showed antiserum had high affinity. The results of Western-blot demonstrated that only AbBRDT-NY1 could specifically recognize endogenous BRDT-NY protein in testis, so it can be used in the following immunohistochemistry experiments.Part 3. Expression study of BRDT-NY protein in human testis and different malignant tumorsTo determine in which types of cells in the testis BRDT-NY protein were expressed, immunohistochemical analysis was carried out using sections of human testis. BRDT-NY protein was detected primarily in the nucleolus of round spermatidsm. Little signal or no signal was detected in the other spermatogenic cells. These results suggest that BRDT-NY may have a role during spermiogenesis.We also examined the expression profile of BRDT-NY protein in human different malignant tumors （44 cases）. The results showed that BRDT-NY protein was detected in 11 of 14 cases of esophageal cancer and 2 of 5 cases non-tumorous esophageal tissues. All 10 cases of gastric cancer expressed BRDT-NY protein. While 2 of 10 cases non-tumorous gastric tissues also had BRDT-NY protein signal. The result had significant difference in statistics （P<0.05）.These results suggested that the incidence of esophageal and gastric tumors was higher than the non-tumorous tissues. BRDT-NY protein may be used as a target for diagnosis and therapy of esophageal and gastric cancer.Among 10 cases of breast cancer, 8 cases showed positive signal of BRDT-NY protein. However, in non-tumorous breast tissues the positive rate was also high （5/7）. But the distribution of the BRDT-NY protein was different in breast cancer and non-tumorous breast tissues. To determine the significance of BRDT-NY protein expression in breast cancer, more cases will need.All of the 5 cases of colon cancer, three cases of thyroid cancer, one case of lung cancer and one case of ovarian cancer, BRDT-NY protein expression were positive. And almost none of the non-tumorous tissues were positive. Further studies with larger sample size may be required to analysis the possibility of BRDT-NY as a target for therapeutic cancer vaccine. In conclusion, BRDT-NY might be used as targets to develop safe and effective gene-based therapy for malignant tumors, especially for esophageal and gastric cancer.

Related Dissertations

  1. The Effects of Pu-erh Tea on Prevetion and Treatment of Tumor,R285.5
  2. Study of Oridonin on SGC-7901 Cell Proliferation by Inhibitting Cell Cycle Proteins,R285
  3. Image-Guided Adaptive Radiation Therapy of Intensity-Modulated Radiation for Cervical Cancer,R737.33
  4. Study the Protective Value of Spect Lung Perfusion to Lung Function in Esophageal Cancer Patients Treated with Radiotherapy,R735.1
  5. The Clinical Research for the Effect of Iodine-125 Seeds Implanted in Advanced Bronchial Lung Cancer,R734.2
  6. Research on the Methods of Nasopharyngeal and Gastric Cancer Detection Based on Surface-enhanced Raman Spectroscopy,R739.63
  7. Synthesis and Quality Control Research of ATPR,TQ463
  8. Methylation of p16 Gene in Plasma and Tissues from Non-small Cell Lung Cancer Patients, Demethylation and the Biological Behavior of Lung Cancer Cell and Transcription of p16 Gene,R734.2
  9. The Value of Diagnosis for Prostate Cancer by Combined Use of MRS and DWI,R737.25
  10. Antitumor Effects of Elemene on the Proliferation Inhibition and Apoptosis Induction in Ascites Hepatoma Cell Line H22,R735.7
  11. Expression and Their Significance of Apoptosis Regulatory Factors Survivin、XIAP and c-Jun、NF-κB in Epithelial Neoplasm of Ovary,R737.31
  12. Inhibitory Role of Plasmodium Yoelii Circumsporozoite Protein on the Proliferation and Survial of Tumor Cell,R730.5
  13. The Experimental Study of Semiconductor Laser Radiation and 5-FU Sustained Release Repressed Oral Malignant Tumor Cell,R739.8
  14. Combined Detection of Tumor Markers in the Diagnosis and Treatment of Lung Cancer to Determine the Clinical Significance,R734.2
  15. The Correlation of Ultrasound Elasticity with the Expressions of Estrogen Receptor, Progestron Receptor, C-erbB-2 in Breast Cancer,R445.1
  16. The Feasibility of the Immunohistochemistry Classification to Predicting Prognosis in Breast Cancer,R737.9
  17. Maximum Tolerated Dose Combined with Metronomic Chemoterpy on Proliferation and Angiogenesis in Treatment of Breast Cancer,R737.9
  18. The Analysis of the M8000/3 Coder of the Lung Cancer Case in a Hospital Between 2006 to 2010,R734.2
  19. Expression of Chemokine Receptor CCR5 in Human Non-small-cell Lung Cancer,R734.2
  20. Effect of Ornithoctonus Huwena Venom on Proliferation of Human Colon Carcinoma Cell SW480 in Vitro,R735.35
  21. Influences of Cisplatin on Expressions of P-glycoprotein in the Resistance Cells of in Lung Cancer Xenografts in the Mice,R734.2

CLC: > Medicine, health > Oncology > Oncology experimental study
© 2012 www.DissertationTopic.Net  Mobile